These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34728300)

  • 1. Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensors.
    Nandi SK; Singh D; Upadhay J; Gupta N; Dhiman N; Mittal SK; Mahindroo N
    Int J Biol Macromol; 2021 Dec; 193(Pt A):838-846. PubMed ID: 34728300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review).
    Ma JYW; Sze YH; Bian JF; Lam TC
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tears as a source of biomarkers for ocular and systemic diseases.
    von Thun Und Hohenstein-Blaul N; Funke S; Grus FH
    Exp Eye Res; 2013 Dec; 117():126-37. PubMed ID: 23880526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear biomarkers.
    Ponzini E
    Adv Clin Chem; 2024; 120():69-115. PubMed ID: 38762243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy.
    Csősz É; Boross P; Csutak A; Berta A; Tóth F; Póliska S; Török Z; Tőzsér J
    J Proteomics; 2012 Apr; 75(7):2196-204. PubMed ID: 22300579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review).
    Król-Grzymała A; Sienkiewicz-Szłapka E; Fiedorowicz E; Rozmus D; Cieślińska A; Grzybowski A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in Tears and Ocular Surface: A Window for Neurodegenerative Diseases.
    Roda M; Ciavarella C; Giannaccare G; Versura P
    Eye Contact Lens; 2020 Mar; 46 Suppl 2():S129-S134. PubMed ID: 31658175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tears and ocular surface disorders: Usefulness of biomarkers.
    Di Zazzo A; Micera A; De Piano M; Cortes M; Bonini S
    J Cell Physiol; 2019 Jul; 234(7):9982-9993. PubMed ID: 30515814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tears - more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease.
    Edman MC; Janga SR; Kakan SS; Okamoto CT; Freire D; Feigenbaum D; Lew M; Hamm-Alvarez SF
    Biomark Med; 2020 Feb; 14(2):151-163. PubMed ID: 32064896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.
    Fujishima H; Okada N; Matsumoto K; Fukagawa K; Igarashi A; Matsuda A; Ono J; Ohta S; Mukai H; Yoshikawa M; Izuhara K
    J Allergy Clin Immunol; 2016 Aug; 138(2):459-467.e2. PubMed ID: 26964692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-chemical markers of chronic, non-infectious disease in the human tear film.
    Alotaibi S; Markoulli M; Ozkan J; Papas E
    Clin Exp Optom; 2022 Mar; 105(2):166-176. PubMed ID: 34592130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear analysis in ocular surface diseases.
    Zhou L; Beuerman RW
    Prog Retin Eye Res; 2012 Nov; 31(6):527-50. PubMed ID: 22732126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
    Zhan X; Li J; Guo Y; Golubnitschaja O
    EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
    Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power of tears: how tear proteomics research could revolutionize the clinic.
    Zhou L; Beuerman RW
    Expert Rev Proteomics; 2017 Mar; 14(3):189-191. PubMed ID: 28117610
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
    Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
    J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms.
    Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J
    J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Applications of Electrochemical Impedance Spectroscopy in Tear Film Analysis.
    Ozdalgic B; Gul M; Uygun ZO; Atçeken N; Tasoglu S
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36290964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.